Australian Healthtech Stock News

ASX:TAM
ASX:TAMMetals and Mining

ASX Penny Stocks: 3 Picks With Market Caps Under A$400M

As the ASX 200 looks to open with a modest rise, driven by international trade talks and local economic developments, investors are keeping a close eye on market movements. Penny stocks, though a somewhat outdated term, continue to pique interest due to their potential for growth at lower price points. By focusing on companies with strong financials and solid fundamentals, investors can uncover opportunities in this often-overlooked segment of the market.
ASX:AD8
ASX:AD8Electronic

High Growth Tech Stocks To Watch In Australia May 2025

As the Australian market anticipates a modest 0.17% gain with the ASX 200 futures pointing upwards, investors are keeping a close eye on tech stocks amid recent global uncertainties and shifting economic dynamics. In this environment, identifying high growth tech companies that demonstrate resilience and adaptability to market fluctuations can be key for those looking to navigate potential opportunities in Australia’s evolving landscape.
ASX:SPD
ASX:SPDMetals and Mining

3 ASX Penny Stocks With Market Caps Below A$300M

As the Australian market prepares for a modest 0.17% gain, investors are keeping a close eye on global events and their potential impact on local indices. For those willing to explore beyond well-known stocks, penny stocks present intriguing opportunities despite being considered an outdated term. These smaller or newer companies often combine affordability with growth potential, and we'll explore three such stocks that stand out for their financial strength and hidden value.
ASX:CSL
ASX:CSLBiotechs

CSL (ASX:CSL) Secures NICE Approval For Sparsentan Use In NHS England

CSL (ASX:CSL) saw its stock price rise by 3% over the last month, amid important developments and a fluctuating market environment. CSL Vifor's notable progress with the National Institute for Health and Care Excellence recommending sparsentan for primary IgA nephropathy treatment may have provided positive momentum. This significant medical endorsement, alongside CSL's continued engagement with shareholders through meetings, could have added weight to its share performance. Meanwhile,...
ASX:CQR
ASX:CQRRetail REITs

Exploring 3 Undervalued Small Caps In Global With Insider Action

As global markets react positively to the recent U.S.-China tariff suspension, with major indices like the Nasdaq Composite and S&P 500 showing significant gains, small-cap stocks have also benefited from this improved sentiment. In this environment of easing trade tensions and cooling inflation, identifying promising small-cap stocks involves looking for those with strong fundamentals and potential insider action that may signal confidence in their future growth.